Purinergic Signaling in Ovarian Carcinoma
Ovarian carcinoma (OC) is the most lethal gynecological cancer worldwide. Around 95% of patients exhibit recurrence five years after treatment; 80% experience recurrence within 18 months after first-line treatment, and progression-free survival rates have not changed over the past 40 years. New ther...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Tabriz University of Medical Sciences
2025-11-01
|
| Серія: | Advanced Pharmaceutical Bulletin |
| Предмети: | |
| Онлайн доступ: | https://apb.tbzmed.ac.ir/PDF/apb-15-779.pdf |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|